BBJX(BJ:430489)2022-04-27 16:00Financial Performance - The company achieved operating revenue of CNY 137,978,313.65, representing a year-on-year increase of 71.50%[16] - Net profit attributable to shareholders reached CNY 16,121,077.09, a significant increase of 207.18% compared to the same period last year[16] - The net profit after deducting non-recurring gains and losses was CNY 12,945,218.69, reflecting an increase of 188.60% year-on-year[16] - Total operating revenue for Q1 2022 reached ¥137,978,313.65, a significant increase of 71.5% compared to ¥80,453,788.81 in Q1 2021[43] - Net profit for Q1 2022 was ¥17,692,461.57, representing a 184.5% increase from ¥6,238,541.70 in Q1 2021[44] - The net profit attributable to the parent company was CNY 12,593,107.32, up 289.5% from CNY 3,237,390.67 in the same period last year[48] - Basic earnings per share increased to CNY 0.19 from CNY 0.07, reflecting a growth of 171.4%[49] Assets and Liabilities - The total assets as of March 31, 2022, amounted to CNY 869,212,288.95, up 4.68% from the end of the previous year[16] - Total assets reached ¥869,212,288.95, up from ¥830,385,178.37, marking a growth of about 4.7%[37] - Total liabilities increased to ¥350,114,615.60 from ¥328,945,568.93, which is an increase of approximately 6.4%[37] - Total liabilities rose to ¥257,038,750.34 in Q1 2022, compared to ¥237,381,710.05 in Q4 2021, an increase of 8.3%[41] - The company's total equity rose to ¥519,097,673.35, compared to ¥501,439,609.44, reflecting an increase of about 3.5%[37] - The company's total equity as of March 31, 2022, was ¥481,083,007.08, compared to ¥468,524,297.42 at the end of 2021, reflecting a growth of 2.3%[41] Cash Flow - The operating cash flow net amount was CNY 3,773,307.32, a decrease of 56.98% year-on-year due to proactive measures taken to secure raw material supplies[19] - The net cash flow from operating activities was CNY 3,773,307.32, down from CNY 8,772,032.59 in Q1 2021[52] - The net cash flow from operating activities in Q1 2022 was CNY -9,857,633.93, a significant decline from CNY 5,920,043.91 in Q1 2021[55] - The cash inflow from financing activities in Q1 2022 was CNY 20,000,000.00, with a net cash flow of CNY 19,020,448.97 after outflows[55] - The ending balance of cash and cash equivalents as of the end of Q1 2022 was CNY 132,206,011.59, down from CNY 176,340,069.40 at the end of Q1 2021[55] - The net increase in cash and cash equivalents for Q1 2022 was CNY -5,341,710.71, compared to CNY -37,017,513.03 in Q1 2021, indicating an improvement in cash flow management[55] Shareholder Information - The total number of unrestricted shares is 52,365,893, accounting for 61.40% of the total share capital[24] - The total number of restricted shares is 32,921,107, representing 38.60% of the total share capital[24] - The total share capital of the company is 85,287,000 shares[24] - The number of shareholders holding ordinary shares is 10,160[24] - The largest shareholder, Bangbu Energy Group, holds 23,400,001 shares, which is 27.44% of the total shares[25] - The second largest shareholder, Bangbu Zhongcheng Venture Capital, holds 6,258,460 shares, accounting for 7.34%[25] - The total shares held by the top ten shareholders amount to 44,570,490, which is 52.26% of the total shares[27] - The company has not issued any preferred shares during this period[28] - The company reported a decrease of 1,284,773 shares held by major shareholders[27] - There are no known relationships or concerted actions among shareholders, except for the control by the state-owned assets supervision[27] Operational Highlights - The company’s gross profit margin improved due to enhanced production processes and cost control measures[18] - The subsidiary, Shafeng New Materials, has commenced production, contributing to stable sales growth[18] - The company continues to focus on market expansion, particularly in the SBM market, which has seen record sales[18] - The company plans to continue expanding its market presence and investing in new product development to sustain growth[52] Research and Development - The company reported R&D expenses of ¥4,957,103.60 in Q1 2022, up from ¥3,277,182.95 in Q1 2021, indicating a 51.2% increase[44] - Research and development expenses for the quarter were CNY 2,183,942.94, an increase of 94.8% from CNY 1,120,949.64 in Q1 2021[48] Other Information - The company has committed to timely disclosures regarding external guarantees and daily related transactions, as per announcements 2022-024 and 2022-025[31] - The company reported no significant litigation or arbitration matters during the reporting period[30] - There were no profit distribution or capital reserve increase plans proposed by the board during the quarter[32] - The company has not engaged in any share repurchase activities during the reporting period[30]